Whiteboard 2 Boardroom
Startup Company Profiles
Whiteboard 2 Boardroom works with research institutions, hospitals and companies to bring their innovations to market. A new effort to further this mission will connect the early-stage companies that have been built around innovations with mentors, board members and other assistance.
If you are interested in supporting an early-stage company, please review the companies below currently looking for support. Don’t see any current needs you’d like to fill? Click the TechSearch button to receive updates in your fields of interest.
ErgoSTM is an intuitive, all-purpose, Ergonomic Instrument-Assisted Soft Tissue Mobilization (IASTM) tool designed with the clinician in mind.
Most existing IASTM tools and their associated systems utilize single edge devices and require clinician education. However, physical therapists, massage therapists, athletic trainers and chiropractors are trained to apply their own technique, expertise, and clinical judgement in using IASTM tools for patient care.
The ErgoSTM Tool, researched and developed by MU inventors, is designed to provide clinicians with the flexibility of using an intuitive, multi-purpose tool for their everyday work. Every edge/surface of the tool is designed to treat different tissue types and areas of the body, while its handle design allows the tool to be held comfortably in multiple ways to fit each clinician’s preference.
ErgoSTM’s innovative, multimodal design offers clinicians who perform IASTM improved ergonomics for optimal clinician performance and convenience, bringing the emphasis back on the clinician and their expertise rather than individual tools and edges. More than 15 Physical Therapists have tested the ErgoSTM Tool and found it ergonomic, intuitive and capable of providing the same standard of care as existing tools marketed for this purpose. Meet ErgoSTM, a new soft tissue therapy tool invented by MU researchers (Video): https://vimeo.com/273568252
University of Missouri – Columbia
Filed United States Patent Application 20160166459
CryoCrate innovates cryopreservation technologies. The CryoCrate trilogy technology platform includes:
1) a cryopreservation medium that enables long-term storage of cells and tissues in normal deep freezers, removing the need for liquid nitrogen facility;
2) a cryoprotective device that achieves high throughput cryopreservation of corneas for corneal transplantation;
3) a versatile cryopreservation device that removes the need for cryoprotectant and realizes in-situ cryopreservation.
CryoCrate licensed the first two inventions from the University of Missouri (MU) with the founder (Xu Han) as the leading inventor, and co-owns the third technology with MU. CryoCrate raised $340K in an angel round investment in 2017. CryoCrate won three NIH SBIRs in three years, the founder is the principal investigator, and the funding totals $550K. The founder and MU research faculty also won two Coulter Transnational Research awards (one for corneal cryopreservation and the other for organ cryopreservation), two MU Fast-track awards (one for stem cell cryopreservation and one for medium GMP production), and a Faculty Innovation Award. The founder is the top reviewer for the journal of Cryobiology and a NIH reviewer for three study sections.
Current CEO, Tim Wheeler, was the previous marketing director of BioMerieux with 30 years of experience in sales and marketing. The current goal of CryoCrate is to raise the second round of investment for commercialization of the corneal cryopreservation technology (Trilogy 2) and prepare for the third round of investment for organ cryopreservation.
University of Missouri – Columbia
Xu Han, CTO & President
Tim Wheeler, Current CEO
White Henry, Science Officer (Former Chair of Dept. of Physics at MU)
Two licensed inventions and one co-owned invention.
One Patent Cooperation Treaty (PCT) filed, one provisional patent, and one PCT soon to be filed.